CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Zibo Qiaosend Medical Articles Co Ltd is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Zibo Qiaosend Medical Articles Co Ltd
No.2 East Gaoyuan Road, Gaoqing County
Phone: +86 5336960828p:+86 5336960828 ZIBO, SDG  256300  China Fax: +86 5336966582f:+86 5336966582

Business Summary
Zibo Qiaosend Medical Articles Co Ltd is a China-based company principally engaged in the research and development, production and sales of disposable medical infusion and blood transfusion medical devices and accessories. The Company's main products include infusion sets, blood transfusion sets, extension tubes, three-way cocks, and various infusion accessories. The Company's distributes its products both in the domestic market and to overseas markets.
(Source: ARS)

Scores and Ratings
FRISK®
Score
Z''
Score
PAYCE®
Score
DBT
Index
Moody's
Rating
Fitch
Rating
DBRS
Rating
-Yes-----

Financials, News and Filings
Latest
Statement
Last
Audit

News
SEC
Filings
Bankruptcy
Filings
Suit &
Judgment
Filings
Tax
Lien
Filings
6/30/201612/31/2015Yes----

General Information
Outstanding Shares: 30,000,000 (As of 6/30/2016)
Fax Number: +86 5336966582


Copyright © 2023 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Friday, July 21, 2023